🔎 Trials Near Me

Hem › Akut lymfoblastisk leukemi › North Carolina

Kliniska studier för Akut lymfoblastisk leukemi i North Carolina

21 studier för Akut lymfoblastisk leukemi söker deltagare vid platser i North Carolina.

Städer i North Carolina

Officiell studietext (engelska)

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

  • AdventHealth Infusion Center Asheville, Asheville
  • Southeastern Medical Oncology Center-Clinton, Clinton
  • AdventHealth Infusion Center Haywood, Clyde
  • och 6 fler
RekryterarObservationsstudieFriska volontärer välkomna
Ålder 40 till 75 · Alla kön · Uppdaterad 2 okt. 2026 · NCT05334069

A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation

  • Duke University Medical Center, Durham
RekryterarFas 1/2
30 Days · Alla kön · Uppdaterad 16 sep. 2026 · NCT04065399

The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

  • Mission Hospital, Asheville
  • UNC Lineberger Comprehensive Cancer Center, Chapel Hill
  • Carolinas Medical Center/Levine Cancer Institute, Charlotte
  • och 4 fler
RekryterarFas 1/2
Upp till ålder 22 · Alla kön · Uppdaterad 25 aug. 2026 · NCT04726241

Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL

  • Levine Children's Hospital, Charlotte
RekryterarFas 2
Ålder 7 till 25 · Alla kön · Uppdaterad 19 aug. 2026 · NCT05082519

Strength Training Exercise in Pediatric Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma (STEP-ALL)

  • University of North Carolina at Chapel Hill, Lineberger Comprehensive Cancer Center, Chapel Hill
RekryterarFriska volontärer välkomna
Ålder 6 och äldre · Alla kön · Uppdaterad 3 aug. 2026 · NCT07634653

Study of AZD3632 Monotherapy or in Combination With Anticancer Agents in Participants With Advanced Haematologic Malignancies With KMT2Ar, NPM1m, or Other Genotypes Associated With HOX Overexpression

  • Research Site, Chapel Hill
  • Research Site, Durham
RekryterarFas 1/2
Ålder 16 och äldre · Alla kön · Uppdaterad 20 juli 2026 · NCT07155226

Therapy for Newly Diagnosed Patients With B-Cell Precursor Acute Lymphoblastic Leukemia and Lymphoma

  • Novant Health Presbyterian Hemby Children's Hospital, Charlotte
RekryterarFas 2
Ålder 1 till 18 · Alla kön · Uppdaterad 16 juli 2026 · NCT06533748

Identification of Necessary Information for Treatment Induction in Newly Diagnosed Acute Lymphoblastic Leukemia/Lymphoma

  • Novant Health Presbyterian Hemby Children's Hospital, Charlotte
RekryterarFas 4
Ålder 1 till 18 · Alla kön · Uppdaterad 14 juli 2026 · NCT06289673

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

  • University of North Carolina at Chapel Hill, Chapel Hill
  • Levine Children's Hospital, Charlotte
  • Duke University Medical Center, Durham
RekryterarObservationsstudie
Alla åldrar · Alla kön · Uppdaterad 6 juli 2026 · NCT01351545

Registry of Older Patients With Cancer

  • Seby B. Jones Cancer Center, Boone
  • Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill
  • East Carolina University, Greenville
  • och 4 fler
RekryterarObservationsstudie
Ålder 65 och äldre · Alla kön · Uppdaterad 29 juni 2026 · NCT01137825

A Study of Revumenib and Mezigdomide in People With Leukemia

  • University of North Carolina (Data Collection Only), Chapel Hill
RekryterarFas 1/2
Ålder 12 och äldre · Alla kön · Uppdaterad 22 juni 2026 · NCT07356154

TINI 2: Total Therapy for Infants With Acute Lymphoblastic Leukemia II

  • Novant Health - Hemby Children's Hospital, Charlotte
RekryterarFas 1/2
Upp till ålder 1 · Alla kön · Uppdaterad 3 juni 2026 · NCT05848687

Study of CM4620 to Reduce the Severity of Pancreatitis Due to Asparaginase

  • Novant Health Presbyterian Hemby Children's Hospital, Charlotte
RekryterarFas 1/2
Upp till ålder 21 · Alla kön · Uppdaterad 3 juni 2026 · NCT04195347

Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment

  • Mission Hospital, Asheville
  • Wake Forest University Health Sciences, Winston-Salem
RekryterarObservationsstudie
Alla åldrar · Alla kön · Uppdaterad 18 maj 2026 · NCT01790152

Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL.

  • University of North Carolina, Chapel Hill
RekryterarFas 1
Ålder 13 och äldre · Alla kön · Uppdaterad 5 maj 2026 · NCT04771572

The Prospective Collection, Storage and Reporting of Data on Patients Undergoing Hematopoietic Stem Cell Transplantation Utilizing a Standard Preparative Regimen

  • Wake Forest Baptist Health, Winston-Salem
RekryterarObservationsstudie
Ålder 18 till 120 · Alla kön · Uppdaterad 13 apr. 2026 · NCT01890486

A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)

  • UNC Hospital, Chapel Hill
  • Duke University, Durham
  • Atrium Wake Forest Baptist Medical Center, Winston-Salem
RekryterarFas 1/2
Ålder 12 och äldre · Alla kön · Uppdaterad 24 mars 2026 · NCT04988555

Pharmacokinetics of Drugs Administered to Children

  • Duke University, Durham
RekryterarObservationsstudie
Ålder 0 till 20 · Alla kön · Uppdaterad 7 jan. 2026 · NCT03481881

Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer

  • Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill
RekryterarObservationsstudie
Ålder 18 till 120 · Alla kön · Uppdaterad 27 okt. 2025 · NCT01137643

Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies

  • Carolina-Levine Children's Hospital, Charlotte
RekryterarFas 1
Ålder 1 till 21 · Alla kön · Uppdaterad 6 dec. 2024 · NCT05476770

Från ClinicalTrials.gov, data hämtad 5 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.